✦ LIBER ✦

A Preliminary Benefit-Risk Assessment of Lamivudine for the Treatment of Chronic Hepatitis B Virus Infection

✍ Scribed by Dr Fabien Zoulim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lamivudine for the treatment of chronic

✍ Sokal, Etienne 📂 Article 📅 2002 🏛 Informa plc 🌐 English ⚖ 191 KB

Prognostic indicators of breakthrough he

✍ Yasuhito Tanaka; Anthony E.T. Yeo; Etsuro Orito; Kiyoaki Ito; Noboru Hirashima; 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 406 KB

Lamivudine therapy for spontaneously occ

✍ Akihito Tsubota; Yasuji Arase; Satoshi Saitoh; Masahiro Kobayashi; Yoshiyuki Suz 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 206 KB

Lamivudine treatment for chronic replica

✍ Picardi, M; Selleri, C; De Rosa, G; Raiola, A; Pezzullo, L; Rotoli, B 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 229 KB

Use of adefovir in the treatment of the

✍ R Barcena Marugan; L Cid Gomez; P Lopez Serrano 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 53 KB

RNAi therapeutics for the treatment of c

✍ C. Wooddell; M. John; M. Hossbach; J. Deckert; P. Hadwiger; H. Hamilton; Q. Chu; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 84 KB